Creative Biolabs provides industry-leading fluorescence modification services for aptamer development, helping researchers transform static sequences into high-sensitivity molecular beacons. Our expertise in site-specific labeling ensures optimal signal-to-noise ratios, solving complex detection challenges in proteomics and metabolic research.
Contact our team to get an inquiry now!Fluorescence modification involves the strategic integration of fluorophores, quenchers, or nanoparticle scaffolds into an aptamer's primary sequence or secondary structure. These "signal-on" or "signal-off" modalities allow for the real-time reporting of molecular recognition events. Unlike antibodies, the small size and chemical modularity of aptamers permit the introduction of diverse optical reporters, including organic dyes (FAM, Cy3, Cy5, ZnPP), quantum dots, and graphene oxide, without compromising binding affinity. By leveraging the conformational flexibility of nucleic acids, such as G-quadruplex formation, intelligent probes can be engineered to remain silent until they encounter their specific target. These modifications are essential for developing rapid assays, high-throughput screening tools, and sophisticated theranostic platforms.
Fig.1 Light-up aptamer as biosensors.1,3
We offer a comprehensive suite of development services designed to create high-performance fluorescent aptasensors. Our team handles everything from initial fluorophore selection and site-specific labeling to the engineering of advanced energy transfer systems for ultra-sensitive detection.
We provide seamless integration of standard organic dyes and dark quenchers during solid-phase synthesis. Our expertise ensures that labels are placed at positions that maximize structural stability and signal recovery.
Utilizing the "double-switch" Bi-FRET mechanism, we develop probes capable of synchronous imaging and sensing. This is particularly effective for monitoring drug release or complex intermolecular interactions where dual-signal reporting is required.
We offer a specialized hydrothermal route where the aptamer serves as the stabilizing ligand during Quantum Dot growth. This results in ultra-small (<10 nm), bio-stable probes with high quantum yields and reduced cytotoxicity compared to traditional conjugation methods.
For aptamers requiring modifications not compatible with automated synthesis, we employ click chemistry (Azide-Alkyne) or thiol-maleimide coupling to achieve precise, 1:1 labeling ratios.
Our scientists optimize the sequence to ensure a dramatic structural transition upon target binding, such as the transition from a random coil to a G-quadruplex, which is critical for "Turn-On" fluorescence applications.
Technical Consultation: We discuss your target (protein, small molecule, or cell), required sensitivity, and detection environment (e.g., buffer vs. serum).
Aptamer Material Intake: Clients provide the aptamer sequence or the raw aptamer candidates from a SELEX pool.
Design & Simulation: We determine the optimal labeling sites (5', 3', or internal) using secondary structure prediction to minimize "Affinity Cost."
Synthesis & Modification: We perform the modification using either solid-phase synthesis or our proprietary "One-Pot" hydrothermal quantum dots conjugation.
Purification & Validation: Probes are purified via HPLC/PAGE. We validate the signal-to-noise ratio and Kd via fluorescence titration.
Final Delivery: You receive the purified, lyophilized fluorescent aptamer, accompanied by a comprehensive QC report including MS/HPLC traces and fluorescence recovery data.
Fig.2 The design of OTA detection based on the structure switch of OTA aptamer.2,3
In this study, a label-free fluorescence sensing platform was developed for the highly sensitive detection of Ochratoxin A (OTA). The mechanism utilizes the OTA-induced conformational transition of a specific aptamer sequence into a G-quadruplex structure. In the presence of the fluorescent probe Zinc(II)-protoporphyrin IX (ZnPP), which specifically binds to G-quadruplexes, a significant enhancement in fluorescence signal is observed upon target recognition. The project achieved an exceptional detection limit of 0.03 nM, demonstrating high selectivity over other competitive mycotoxins. This research underscores the ability to engineer aptasensors that leverage structural switches for robust performance in complex food matrices, such as corn and red wine.
A: We utilize advanced secondary structure modeling to identify specific "loops" or termini that are not involved in target recognition. By placing the fluorophore in these non-essential regions, we minimize the "Affinity Cost." If binding is impacted, we can introduce a flexible PEG spacer between the aptamer and the dye to reduce steric hindrance.
A: We offer both options. While 5' and 3' labeling is most common and cost-effective for most researchers, we can incorporate fluorescently modified nucleotides (e.g., Fluorescein-dT) internally during synthesis. This is often necessary for specialized FRET-based molecular beacons where the distance between the donor and acceptor must be precisely controlled.
A: Yes, we recommend a "Stability Package" alongside fluorescence modification. This includes 2'-Fluorine or 2'-O-Methyl ribose modifications and 3'-inverted thymidine capping. These structural changes prevent nuclease degradation, ensuring your fluorescent signal accurately reflects target binding rather than non-specific probe breakdown in biological matrices.
A: In One-Pot synthesis, the aptamer is present during the actual formation of the Quantum Dot. This creates a direct, robust bond and ensures that the aptamer is perfectly oriented on the surface. Traditional coupling can lead to random orientation and larger hydrodynamic sizes, which can significantly interfere with cell penetration and binding kinetics.
A: Absolutely. We can synthesize a custom panel of aptamers labeled with dyes that have non-overlapping emission spectra (e.g., FAM, Cy3, and Cy5). This allows you to monitor multiple unique targets simultaneously within a single sample or cell without signal crosstalk.
A: Yes, our bioinformatics team can design the complementary "quencher" strand or identify the best donor-acceptor pair based on your specific aptamer sequence and the expected conformational change upon binding. We provide full support from theoretical design to experimental verification.
Creative Biolabs' expertise in fluorescence modification empowers your research with ultra-sensitive, real-time molecular recognition tools. Our scientists are ready to help you design the perfect optical probe for your specific application. Contact us today to discuss your project requirements.
| Cat# | Product Type | Product Name | Specie Reactivity | Applications | Inquiry |
|---|---|---|---|---|---|
| CTS-006 | Serum | Human Complement Serum (Pooled) | Human | Complement fixation assays; Haemolysis Assays | INQUIRY |
| CTS-001 | Serum | Guinea Pig Complement Serum | Guinea pig | Complement fixation assays; Haemolysis Assays | INQUIRY |
| CTR-001 | Antibody | Hemolysin (Rabbit Anti-Sheep Cell Hemolysin) | Sheep | Complement fixation assays; Haemolysis Assays | INQUIRY |
| CTP-461 | Protein | Native Human Complement C1q Protein | Human | ELISA; Functional Assays | INQUIRY |
| CTP-463 | Protein | Native Mouse Complement C1q Protein | Mouse | ELISA; Functional Assays | INQUIRY |
| CTMM-0322-JL15 | Antibody | Mouse Anti-Human C1q Monoclonal Antibody (TJL-03) [HRP] | Human | WB; IHC; ELISA | INQUIRY |
| CTP-051 | Protein | Native Human Complement C3b Protein | Human | ELISA; Functional Assays | INQUIRY |
| CTP-456 | Protein | Native Cynomolgus Monkey Complement C3b Protein | Cynomolgus Monkey | ELISA; Functional Assays | INQUIRY |
| CTApt-113 | Aptamer | Anti-Thrombin Aptamer | Anticoagulant Studies; Structural Complexes; Coagulation Monitoring | INQUIRY | |
| CTApt-217 | Aptamer | Anti-Interleukin 6 (IL-6) Aptamer | ELISA-Like Detection; Inflammatory Disease Screening | INQUIRY | |
| CTApt-615 | Aptamer | Anti-EGFR Aptamer | Targeted Delivery; Cell Internalization; Molecular Imaging | INQUIRY |
References
A: Commonly used fluorophores in aptamer modifications include FAM, Cy3, Cy5, and iFluor® dyes. Cy3 and Cy5 are suitable for fluorescence resonance energy transfer (FRET) experiments, and iFluor® dyes offer exceptional brightness and photostability. The choice of fluorophore depends on the specific application, such as imaging, biosensing, or flow cytometry.
A: Incorporating multiple fluorescence modifications can be challenging due to the potential for structural disruptions and decreased binding affinity. Researchers must carefully balance the number and placement of modifications to maintain aptamer functionality. Additionally, increased complexity can make synthesis and purification more demanding.
A: Recent advancements include the development of new fluorophores with improved properties, such as enhanced brightness and photostability. Additionally, researchers have been exploring advanced techniques like DNA nanotechnology to precisely position fluorophores within aptamer structures, allowing for better control over their effects on binding affinity and specificity.